ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1206

Association of Effusion-synovitis on Knee Pain in Early and Later-stage Knee Osteoarthritis

Lindsey MacFarlane1, Mike Paskewicz2, Jamie Collins2 and Jeffrey Katz2, 1Brigham and Women's Hospital, Hanover, NH, 2Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Inflammation, Osteoarthritis, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Pain in knee osteoarthritis (OA) is associated with structural features including effusion-synovitis (E-S) and radiographic severity. Prior studies show a cross-sectional association between larger E-S and increased pain, though this association is not always seen longitudinally. We investigated whether the association of pain and E-S varied in patients with early versus later stage knee OA.

Methods: We used data from Osteoarthritis Registry of Biomarkers and Imaging Trajectories (ORBIT), an observational cohort of 101 patients with symptomatic and radiographic knee OA. Participants underwent bilateral standing knee radiographs, and bilateral knee MRIs at baseline, 12 and 24mo. We assessed knee pain with Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain score (0-100, 100 worst). Radiographs were graded according to the Kellgren-Lawrence Score (KL, 0-4). E-S was graded on MRIs according to the MRI Osteoarthritis Knee Score (MOAKS;  0-3, 3 most severe).

We considered all knees at all timepoints. We dichotomized E-S to none/small (E-S 0-1) and medium/large (E-S 2-3), and KL to early (KL 0- 2) and late stage (KL 3-4). We used linear regression with GEE (to account for clustering between knees and across timepoints) to investigate the association between KOOS Pain (dependent variable) and E-S and KL grade. We then included both E-S, KL and the interaction between E-S and KL in the same model to determine whether the effect of E-S on pain varied by KL grade. We adjusted for age, sex, and BMI.

Results: The sample included 420 knees (all participants at all timepoints with imaging data). The mean age of the cohort was 64 years (SD 10), mean BMI 30 (SD 6) and 63% were female. At baseline 37% had knee symptoms for less than 2 years.

Across all timepoints 199 (47%) knees were early KL stage and 221 (53%) late stage. None/small E-S was seen in 263 (63%) and medium/large in 57 (37%). Table 1. Individually, the least squares means (LSM) KOOS Pain score for none/small E-S was 32 and for medium/large 36 (mean difference 4 (95% CI 0.7,8)), while the LSM for early KL was 28 and late KL 39 points (mean difference 10 (95% CI 6,14; Table 2). Including both E-S and KL in the model slightly diminished the magnitude of association. The interaction between E-S and KL on pain was statistically significant (p=0.02).  In patients with later stage KL the presence or absence of E-S changed pain levels by a mean difference of 0.4 (95% CI -4,4). In contrast among those in the early KL group, those with none/small E-S had a LSM of 26 for KOOS Pain while those with medium/large E-S had an LSM of 34 (mean difference 8 (95% CI 2,14); Table 2).

Conclusion: In participants with symptomatic and radiographic knee OA, the association of E-S and pain differed based on radiographic OA severity.  In early-stage OA the presence of medium/large E-S was associated with a 8-point worsening in KOOS Pain, approaching a clinically important effect. In later stage (KL 3-4), the presence of E-S was associated with 0.4 point mean difference. These data raise the question as to whether anti-inflammatory treatments may be more effective in early-stage knee OA.

Supporting image 1

Table 1. Baseline characteristics

Supporting image 2

Table 2. Association between effusion-synovitis, Kellgren-Lawrence grade and pain


Disclosures: L. MacFarlane: None; M. Paskewicz: None; J. Collins: Boston Imaging Core Lab LLC, 2; J. Katz: None.

To cite this abstract in AMA style:

MacFarlane L, Paskewicz M, Collins J, Katz J. Association of Effusion-synovitis on Knee Pain in Early and Later-stage Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/association-of-effusion-synovitis-on-knee-pain-in-early-and-later-stage-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-effusion-synovitis-on-knee-pain-in-early-and-later-stage-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology